MWE China Law Offices and its strategic alliance partner McDermott Will & Emery are proud to co-host our annual Shanghai Life Sciences Forum in partnership with the Redefining Early Stage Investments (RESI) conference.
This...more
10/30/2019
/ Acquisitions ,
Corporate Governance ,
Cross-Border Transactions ,
Events ,
Foreign Investment ,
Health Care Providers ,
Investment Funds ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Devices ,
Mergers ,
Outbound Transactions ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Regulatory Requirements ,
Venture Capital
Privacy Shield Implementation and How-To Kit from McDermott Will & Emery -
Japanese companies may have European branches or subsidiaries that send personal data to the US or that may be accessed by entities in the US,...more
Overview of the Proposed Reforms of the EU Merger Control Regime -
In October 2016, the European Commission launched a public consultation to continue the process of identifying possible areas of the EU Merger Regulation...more
12/5/2016
/ 28 U.S.C. ยง 1782 ,
Acquisitions ,
Arbitration ,
Chile ,
China ,
Competition ,
Defend Trade Secrets Act (DTSA) ,
EU ,
European Merger Control Regulation ,
Foreign Investment ,
Healthcare ,
Member State ,
Mergers ,
Shareholders ,
Statute of Limitations ,
Trade Secrets
On 24 November 2014, the Ministry of Commerce (MOFCOM) and the Ministry of Civil Affairs (MCA) of China jointly issued the Announcement Encouraging Foreign Investors to Establish For-Profit Senior Care Institutions to Engage...more
On 28 August 2014, the Ministry of Commerce (MOFCOM) and the National Health and Family Planning Commission (HFPC) jointly released the Notice of the National Health and Family Planning Commission and the Ministry of Commerce...more
The Chinese foreign exchange control authority recently adopted material changes to the regulatory framework on overseas financing and investment via special purpose vehicles undertaken by Chinese domestic residents and the...more